文献速递围术期管理与 ERAS急腹症与外科感染

妇科腹腔镜手术皮肤消毒液对手术部位感染的影响:双盲随机临床试验

Effect of Surgical Skin Antisepsis on Surgical Site Infections in Patients Undergoing Gynecological Laparoscopic Surgery: A Double-Blind Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2020-01-01

该双盲随机试验纳入661例接受良性妇科疾病择期腹腔镜手术的患者,按1:1:1随机使用醇基氯己定、醇基聚维酮碘或水基聚维酮碘进行术前皮肤消毒。640例纳入改良意向性分析,术后30天戳卡部位感染率为10.2%,器官/腔隙感染率为6.6%,任何手术部位感染率为16.3%;三种消毒液在降低感染率方面无显著差异。

要点

  • 妇科腹腔镜术后手术部位感染率高于预期,戳卡部位感染率达10.2%。
  • 醇基氯己定、醇基聚维酮碘与水基聚维酮碘在降低戳卡部位感染方面无显著差异。
  • 临床应关注妇科腹腔镜术后手术部位感染的监测与预防。

核心结论

  • 妇科腹腔镜手术后手术部位感染率高于预期,三种皮肤消毒液在减少感染率方面均无优势。

研究设计与样本

  • 共661例18岁及以上因良性妇科疾病行择期腹腔镜手术的患者,按1:1:1随机分配至醇基氯己定、醇基聚维酮碘或水基聚维酮碘组。
  • 640例(96.8%)完成术后医生检查并纳入改良意向性分析,平均(SD)年龄36.2(10.6)岁。

主要发现

  • 术后30天戳卡部位感染总体发生率为10.2%(65/640)。
  • 器官或腔隙感染发生率为6.6%(42/640)。
  • 任何类型手术部位感染发生率为16.3%(104/640)。
  • 醇基氯己定 vs 水基聚维酮碘的戳卡部位感染OR为1.13(95%CI 0.61-2.08)。
  • 醇基氯己定 vs 醇基聚维酮碘的OR为1.34(95%CI 0.71-2.52);水基聚维酮碘 vs 醇基聚维酮碘的OR为1.19(95%CI 0.62-2.27)。

临床怎么用

  • 妇科腹腔镜术前皮肤消毒液的选择无需优先考虑某种特定溶液以降低手术部位感染。
  • 应加强术后手术部位感染的监测,尤其关注戳卡部位和器官/腔隙感染。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Gynecological laparoscopies are one of the most common surgical procedures worldwide. Limited evidence exists on rates of surgical site infections in patients undergoing gynecological laparoscopies and strategies to prevent these infections. OBJECTIVE: To compare rates of port-site infections, organ or space infections, and any type of surgical site infections among patients who underwent gynecological laparoscopies and received 1 of 3 types of skin preparation solutions. DESIGN, SETTING, AND PARTICIPANTS: A double-blind randomized clinical trial was conducted between February 28, 2017, and November 26, 2018, at a tertiary university-affiliated referral center. A total of 661 patients 18 years or older who underwent an elective operative laparoscopy for treatment of nonmalignant gynecological disorders were randomly assigned in a 1:1:1 ratio to have their skin cleaned before surgery with alcohol-based chlorhexidine, alcohol-based povidone-iodine, or water-based povidone-iodine. Statistical analysis was performed from February 28, 2017, to November 26, 2018. Analyses were performed on a modified intention-to-treat basis. INTERVENTIONS: A total of 221 patients were randomized to have their skin prepared preoperatively with water-based povidone-iodine, 220 were randomized to alcohol-based povidone-iodine, and 220 were randomized to alcohol-based chlorhexidine. The patients were blinded to the solution used to clean their skin. Patients were followed up 1 and 4 weeks after surgery by a physician who was blinded to the skin preparation solution used at surgery. Evidence of infection according to Centers for Disease Control and Prevention criteria were documented. MAIN OUTCOMES AND MEASURES: The primary outcome of this study was port-site infection 30 days after surgery. Secondary outcomes were organ or space infections and any type of surgical site infections; the study also aimed to prospectively describe rates of surgical site infections in gynecological laparoscopies. RESULTS: Of the 661 patients, 640 (96.8%; mean [SD] age, 36.2 [10.6] years) were examined after surgery by a physician at the study site and were included in the modified intention-to-treat analysis. The overall rate of port-site infection was 10.2% (65 of 640), rate of organ or space infection was 6.6% (42 of 640), and rate of any surgical site infection was 16.3% (104 of 640). The odds ratio for port-site infection for alcohol-based chlorhexidine vs water-based povidone-iodine was 1.13 (95% CI, 0.61-2.08), for alcohol-based chlorhexidine vs alcohol-based povidone-iodine was 1.34 (95% CI, 0.71-2.52), and for water-based povidone-iodine vs alcohol-based povidone-iodine was 1.19 (95% 0.62-2.27). CONCLUSIONS AND RELEVANCE: Surgical site infections were more common than expected among patients who underwent gynecological laparoscopies. No skin preparation solution provided an advantage compared with the other solutions in reducing infection rates. TRIAL REGISTRATION: http://anzctr.org.au Identifier: ACTRN12617000475347.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Dior UP, Kathurusinghe S, Cheng C, et al. Effect of Surgical Skin Antisepsis on Surgical Site Infections in Patients Undergoing Gynecological Laparoscopic Surgery: A Double-Blind Randomized Clinical Trial. JAMA Surg. 2020. PMID: 32639545. doi:10.1001/jamasurg.2020.1953

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。